Overview
  • Recommended for the vaccination of healthy dogs 6 weeks of age and older for the prevention of disease due to canine distemper virus, adenovirus types 1& 2 and parvovirus
  • Contains a lyophilized suspension of a recombinant canarypox vector expressing the HA and F glycoproteins of canine distemper virus, modified live adenovirus type 2, and parvovirus
  • Subcutaneously or intramuscular injection